Moderna Says New Data Supports Its COVID-19 Vaccine For Children 6-11
Mohammad Ali (@ChaudhryMAli88) Published October 26, 2021 | 01:51 PM
American biotechnology company Moderna said Tuesday a study in children ages 6 to 11 found two doses of the company's COVID-19 vaccine given 28 days apart produced a strong antibody respons
WASHINGTON, Oct. 26 (UrduPoint / Pakistan Point News - 26th Oct, 2021 ) --:American biotechnology company Moderna said Tuesday a study in children ages 6 to 11 found two doses of the company's COVID-19 vaccine given 28 days apart produced a strong antibody response.
The Phase 2/3 study, called the KidCOVE study, gave participants two 50 mcg doses of the Moderna COVID-19 vaccine mRNA-1273, half the dose authorized for adults.
A total of 4,753 participants ages 6 to less than 12 years were enrolled in the study, which aims to evaluate the safety, tolerability, reactogenicity and effectiveness of the Moderna vaccine in kids, according to the company.
The interim analysis showed a "robust neutralizing antibody response" after two doses given 28 days apart, according to Moderna.
Related Topics
Recent Stories
UHS declares MBBS first prof, MS urology exam results
Separate coaches to be hired for ODIs, Test and T20I formats
Finance Minister calls for reforming tax system to improve country's economy
PM calls for joint efforts to check smuggling, power theft
Infinix Unveils a Vibrant New Chapter with Wahaj Ali: The face of Infinix NOTE 4 ..
PM makes two more appointments in his team
Terrorists of Shangla suicide attack will be brought to justice: Interior Minist ..
Applications Open for 6th Cycle of Start-up Incubation under the National Expans ..
Join vivo's "Light it Up" Social Media Contest in Ramadan to Win vivo V30 5G
Pakistan v New Zealand T20I series: Tickets to go on sale from today
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 29 March 2024
Today Gold Rate in Pakistan 29 March 2024
More Stories From Health
-
UHS declares MBBS first prof, MS urology exam results
2 hours ago -
Increased diagnostic testing for drug resistance
6 days ago -
IRD releases groundbreaking results of end TB programme
8 days ago -
Increased diagnostic testing for drug resistance TB will enhance patients’ treatment outcome
11 days ago -
JRF to provide insulin to underprivileged diabetic patients
13 days ago -
MBBS third professional annual exams 2023: check results here
14 days ago
-
CM Maryam visits PIC, inquiries after patients
16 days ago -
Health expert recommends exercise for weight loss in Ramazan
18 days ago -
Blood camp held at SNGPL office
18 days ago -
Free Medical camp for people with mental, physical disabilities
24 days ago -
Breast cancer has become most common disease in few years: expert
24 days ago -
Punjab Healthcare Commission shuts down 634 illegal treatment centers
24 days ago